VENENO TECHNOLOGIES
Veneno Technologies develops drug candidates for pharmaceutical companies. The company provides services that include the treatment of neurological, cardiovascular, and metabolic diseases, cancer cell proliferation, metastasis, and immune cell regulation.
VENENO TECHNOLOGIES
Social Links:
Industry:
Biotechnology Information Technology Medical Therapeutics
Founded:
2020-07-01
Address:
Tsukuba, Ibaraki, Japan
Country:
Japan
Website Url:
http://www.veneno.jp
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
200 M JPY
Technology used in webpage:
Amazon GMO Internet DNS
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Investors List
SBI Investment
SBI Investment investment in Seed Round - Veneno Technologies
SBI regional activation support Co., Ltd.
SBI regional activation support Co., Ltd. investment in Seed Round - Veneno Technologies
Tsukuba Institute of Research
Tsukuba Institute of Research investment in Seed Round - Veneno Technologies
Official Site Inspections
http://www.veneno.jp Semrush global rank: 6.85 M Semrush visits lastest month: 980
- Host name: www311.onamae.ne.jp
- IP address: 160.251.71.117
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Veneno Technologies"
VENENO TECHNOLOGIES
We were selected as a Top 10 BioTech Startups In APAC – 2021 COMPANY OF THE YEAR by Life Sciences Review. We focus on two business models with a mission to develop peptide drugs and agrochemical ingredients based on …See details»
Veneno Technologies - Crunchbase Company Profile
Veneno Technologies develops drug candidates for pharmaceutical companies. The company provides services that include the treatment of neurological, cardiovascular, and metabolic diseases, cancer cell proliferation, metastasis, …See details»
Veneno Technologies Co. Ltd. - VentureRadar
Website: https://veneno.co.jp/ Veneno Technologies was established in July 2020 to accelerate the research and development of therapeutic Disulfide-Rich Peptides (DRP) and contribute to …See details»
Veneno Technologies - Products, Competitors, Financials, …
Veneno Technologies focuses on the development of therapeutic peptides for drug discovery in the pharmaceutical sector. Use the CB Insights Platform to explore Veneno Technologies's full …See details»
Veneno Technologies Co. Ltd. - LinkedIn
Veneno Technologies Co. Ltd. | 72 followers on LinkedIn. Creating therapeutic Disulfide-Rich Peptides targeting transmembrane proteins including ion channels,GPCRs, and transporters.See details»
Veneno Technologies, a Novel DRP Drug Discovery Company, …
Apr 18, 2023 · Under the terms of the agreement, Veneno Technologies [https://veneno.jp/] will conduct a program to obtain functional peptides (DRPs) for ion channels targeted by …See details»
Technology – VENENO TECHNOLOGIES
The Veneno Suite enables the construction of DRP genetic libraries based on DRP genomic, structural, and physicochemical information. The DRP Space provides libraries of enormous diversity, which conventional chemical …See details»
Veneno Technologies - Overview, News & Similar companies
Jan 28, 2022 · View Veneno Technologies (www.veneno.co.jp) location in Ibaraki, Japan , revenue, industry and description. Find related and similar companies as well as employees …See details»
KYORIN and Veneno Technologies conclude Joint Research …
Veneno’s technological competitiveness and business concept have been highly evaluated, and AIST Solutions, a subsidiary of the National Institute of Advanced Industrial Science and …See details»
Veneno Technologies Co. Ltd. , a Novel Bio-Active DRP Discovery …
Jan 22, 2024 · Under the terms of the agreement, Veneno https://veneno.jp/] will implement a [program to obtain functional Disulfide-Rich Peptides (DRPs) using our next-generation …See details»
VENENO TECHNOLOGIES CO., LTD. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VENENO TECHNOLOGIES CO., LTD. of TSUKUBA, IBARAKI. Get the latest business insights from …See details»
Veneno Technologies, a Novel DRP Drug Discovery Company, …
Jan 26, 2022 · Our mission is to contribute to the advancement of medicine by providing new drugs for targets such as membrane proteins that have been difficult to discover, and for …See details»
Veneno Technologies Co. Ltd. | Insights
Veneno Technologies Co. Ltd. https://veneno.jp/ Industry. Pharmaceuticals; Biotechnology. Drug Discovery Technologies. Molecular Diversity. Natural Products; See more in Biomedtracker. …See details»
Veneno Technologies, a Novel DRP Drug Discovery Company, has …
Apr 11, 2023 · Under the terms of the agreement, Veneno [https://veneno.jp/] will conduct a program to obtain functional peptides (DRPs) for G protein-coupled receptors (GPCRs) …See details»
Veneno Technologies, a Novel DRP Drug Discovery Company, …
Under the terms of the agreement, Veneno Technologies [https://veneno.jp/] will conduct a program to obtain functional peptides (DRPs) for ion channels targeted by Sumitomo Pharma …See details»
Veneno Technologies, a Novel DRP Drug Discovery Company, has …
Under the terms of the agreement, Veneno [https://veneno.jp/] will conduct a program to obtain functional peptides (DRPs) for G protein-coupled receptors (GPCRs) targeted by Astellas …See details»
Veneno Technologies, a Novel DRP Drug Discovery Company, …
Jan 26, 2022 · Veneno Suiteâ„¢ is the Company's proprietary integrated DRP drug discovery technology. The Veneno Suiteâ„¢ consists of a large gene library that is created by artificially …See details»
Inspiring panel of global investors discuss opportunities for …
Jan 30, 2023 · Eight deep tech startups from the BRAVE GLOBAL program participated in this event, along with global VCs firms such as Insight Partners, IP Group Inc., ARCH Venture …See details»
2021 – VENENO TECHNOLOGIES
Mar 15, 2021 · We are pleased to announce that we have been selected as COMPANY OF THE YEAR in the Top 10 BioTech Startups In APAC – 2021 […] Veneno Technologies Co. Ltd. and …See details»
Veneno Technologies, a Novel DRP Drug Discovery Company, has …
Apr 10, 2023 · Under the terms of the agreement, Veneno [https://veneno.jp/] will conduct a program to obtain functional peptides (DRPs) for G protein-coupled receptors (GPCRs) …See details»